enGene to Participate in Upcoming Investor Conferences
BOSTON & MONTREAL — enGene Holdings Inc. (Nasdaq: ENGN or "enGene"), a clinical-stage, non-viral genetic medicines company, today announced that management will participate in the following investor conferences in November: Guggenheim 2nd Annual Healthcare In
(Financial Post, 2025-11-06T22:10:17Z)